Dr Toni Choueiri discusses a new Phase 2 clinical trial on volitinib in patients with papillary renal cell carcinoma (pRCC)

At the Thirteenth International Kidney Cancer Symposium, Dr Toni Choueiri (Dana-Farber Cancer Institute and Harvard Medical School, MA) discusses the new AstraZeneca-sponsored Phase 2 clinical trial o... Author: EMJ Added: 11/26/2014
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts